10:07 AM EST - Oncolytics Biotech ® Inc. : Announced that Dr. Matt Coffey , the Company's President and Chief Executive Officer, will be participating in a panel discussion at the Canaccord Genuity Horizons in Oncology Virtual Conference. The address, entitled “Off-the-Shelf CAR T - solid tumors, myeloma, lymphoma,” is slated for Thursday, April 15, at 8:15 a.m. ET. Oncolytics Biotech ® Inc.
shares T.ONC are trading up $0.30 at $5.78.